• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor re: "Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake".

作者信息

Werner Rudolf A, Pienta Kenneth J, Pomper Martin G, Gorin Michael A, Rowe Steven P, Lodge Martin A, Bundschuh Ralph A

机构信息

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.

出版信息

Mol Imaging Biol. 2020 Feb;22(1):19-21. doi: 10.1007/s11307-019-01452-0.

DOI:10.1007/s11307-019-01452-0
PMID:31832870
Abstract
摘要

相似文献

1
Letter to the Editor re: "Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake".致编辑的信：关于“[F]DCFPyL靶向PET成像中的半定量参数：肿瘤负荷对正常器官摄取的影响”
Mol Imaging Biol. 2020 Feb;22(1):19-21. doi: 10.1007/s11307-019-01452-0.
2
Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.致编辑的信：关于使用[F]DCFPyL进行PSMA靶向PET成像中的半定量参数：肿瘤负荷对正常器官摄取的影响
Mol Imaging Biol. 2020 Feb;22(1):15-17. doi: 10.1007/s11307-019-01438-y.
3
Semiquantitative Parameters in PSMA-Targeted PET Imaging with F-DCFPyL: Variability in Normal-Organ Uptake.使用F-DCFPyL进行PSMA靶向PET成像的半定量参数：正常器官摄取的变异性
J Nucl Med. 2017 Jun;58(6):942-946. doi: 10.2967/jnumed.116.179739. Epub 2016 Dec 8.
4
Correction to: Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.对以下内容的更正：致编辑的信：关于使用[18F]DCFPyL进行PSMA靶向PET成像中的半定量参数：肿瘤负荷对正常器官摄取的影响。
Mol Imaging Biol. 2020 Feb;22(1):18. doi: 10.1007/s11307-019-01448-w.
5
[F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.[F]-DCFPyL 正电子发射断层扫描/磁共振成像在显性前列腺内焦点定位中的应用：初步经验。
Eur Urol Focus. 2018 Sep;4(5):702-706. doi: 10.1016/j.euf.2016.10.002. Epub 2016 Oct 26.
6
[(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance.[18F]氟乙基三唑取代的PSMA抑制剂，具有快速的正常器官清除率。
Bioconjug Chem. 2016 Jul 20;27(7):1655-62. doi: 10.1021/acs.bioconjchem.6b00195. Epub 2016 Jun 24.
7
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL in peripheral ganglia.外周神经节中前列腺特异性膜抗原（PSMA）靶向的F-DCFPyL摄取模式。
Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.
8
Healthy Tissue Uptake of Ga-Prostate-Specific Membrane Antigen, F-DCFPyL, F-Fluoromethylcholine, and F-Dihydrotestosterone.健康组织对 Ga-前列腺特异性膜抗原、F-DCFPyL、F-氟甲基胆碱和 F-二氢睾酮的摄取。
J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10.
9
Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.一类用于正电子发射断层扫描（PET）成像检测前列腺癌的新型高亲和力F标记前列腺特异性膜抗原（PSMA）配体的合成及临床前评估。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15.
10
Discovery of F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions.发现 F-JK-PSMA-7，一种用于检测小 PSMA 阳性病变的 PET 探针。
J Nucl Med. 2019 Jun;60(6):817-823. doi: 10.2967/jnumed.118.218495. Epub 2018 Nov 2.

本文引用的文献

1
Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.致编辑的信：关于使用[F]DCFPyL进行PSMA靶向PET成像中的半定量参数：肿瘤负荷对正常器官摄取的影响
Mol Imaging Biol. 2020 Feb;22(1):15-17. doi: 10.1007/s11307-019-01438-y.
2
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using Ga-DOTATOC and Ga-DOTATATE.使用 Ga-DOTATOC 和 Ga-DOTATATE 评估神经内分泌肿瘤中生长抑素受体密度的肿瘤与血比值。
J Nucl Med. 2020 Feb;61(2):217-221. doi: 10.2967/jnumed.119.228072. Epub 2019 Jul 13.
3
Prospective Evaluation of PSMA-Targeted F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer.
前列腺癌根治术后生化失败患者 PSMA 靶向 F-DCFPyL PET/CT 的前瞻性评估。
J Nucl Med. 2020 Jan;61(1):58-61. doi: 10.2967/jnumed.119.226514. Epub 2019 Jun 14.
4
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.[F]DCFPyL 标记的 PSMA 靶向 PET 成像中的半定量参数：肿瘤负荷对正常器官摄取的影响。
Mol Imaging Biol. 2020 Feb;22(1):190-197. doi: 10.1007/s11307-019-01375-w.
5
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.[F]DCFPyL 标记的 PSMA 靶向 PET 成像中的半定量参数：正常器官摄取的患者内和患者间变异性。
Mol Imaging Biol. 2020 Feb;22(1):181-189. doi: 10.1007/s11307-019-01376-9.
6
Simplified Methods for Quantification of F-DCFPyL Uptake in Patients with Prostate Cancer.简化方法定量分析前列腺癌患者 F-DCFPyL 摄取。
J Nucl Med. 2019 Dec;60(12):1730-1735. doi: 10.2967/jnumed.119.227520. Epub 2019 Apr 18.
7
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.68Ga-PSMA-11 PET 定位复发性前列腺癌的准确性评估：一项前瞻性单臂临床试验。
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
8
Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.化疗初治的晚期前列腺癌患者中 Ac-PSMA-617 的初步研究。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138. doi: 10.1007/s00259-018-4167-0. Epub 2018 Sep 19.
9
Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.前列腺癌的诊疗一体化：从分子成像到靶向前列腺特异性膜抗原的精准分子放疗
Br J Radiol. 2018 Nov;91(1091):20180308. doi: 10.1259/bjr.20180308. Epub 2018 Jun 1.
10
[Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.[镥]-PSMA-617 放射性核素治疗转移性去势抵抗性前列腺癌患者（LuPSMA 试验）：一项单中心、单臂、2 期研究。
Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8.